Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II/III trial

2018 ◽  
Vol 68 ◽  
pp. S123-S124 ◽  
Author(s):  
I. Andrieux-Meyer ◽  
S.-S. Tan ◽  
N. Salvadori ◽  
F. Simon ◽  
T.R. Cressey ◽  
...  
2019 ◽  
Vol 34 (9) ◽  
pp. 1597-1603 ◽  
Author(s):  
Lai Wei ◽  
Hiromitsu Kumada ◽  
Ponni V Perumalswami ◽  
Tawesak Tanwandee ◽  
Wendy Cheng ◽  
...  

2006 ◽  
Vol 131 (2) ◽  
pp. 478-484 ◽  
Author(s):  
Omana V. Nainan ◽  
Miriam J. Alter ◽  
Deanna Kruszon-Moran ◽  
Feng-Xiang Gao ◽  
Guoliang Xia ◽  
...  

2018 ◽  
Vol 91 (3) ◽  
pp. 518-521 ◽  
Author(s):  
Luis Filipe da Costa Marques Borges ◽  
Mariano Gustavo Zalis ◽  
Guilherme Santoro-Lopes ◽  
Rafael Brandão Varella

2016 ◽  
Vol 22 (34) ◽  
pp. 7824 ◽  
Author(s):  
Arnolfo Petruzziello ◽  
Samantha Marigliano ◽  
Giovanna Loquercio ◽  
Anna Cozzolino ◽  
Carmela Cacciapuoti

2020 ◽  
Vol 24 (4) ◽  
pp. 304-309 ◽  
Author(s):  
Geison Luiz Costa de Castro ◽  
Ednelza da Graça Silva Amoras ◽  
Mauro Sérgio Moura de Araújo ◽  
Simone Regina Souza da Silva Conde ◽  
Antonio Carlos R. Vallinoto

Sign in / Sign up

Export Citation Format

Share Document